Fusion gene tests

The HUS Group, the joint authority for Helsinki and Uusimaa requests for offers on fusion gene tests. The products will be used by HUS Diagnostic Center, laboratory of genetics. The agreement is in force for a fixed period of two (2) years, and thereafter until terminated. The Client will select one (1) supplier with which it will enter into an agreement. The object of the procurement and the requirements pertaining to it are described in detail in the call for tenders and its appendices.

The HUS Group, the joint authority for Helsinki and Uusimaa requests for offers on fusion gene tests. The products requested in this call for tenders will be used by HUS Diagnostic Center, laboratory of genetics. The object of procurement includes also the analysis software, and licenses for five workstations. The estimated annual number of fusion gene tests performed is as followes: Sarcoma: 150 samples/year Solid tumors: 350 samples/year Hematologic: 250 samples/year However, this is just an estimate based on the consumption of the previous year. This estimate does not obligate the Client to purchase any specific quantity. The agreement is in force for a fixed period of two (2) years, and thereafter until terminated. The Client will select one (1) supplier with which it will enter into an agreement. The object of the procurement and the requirements pertaining to it are described in detail in the call for tenders and its appendices.

Tender competition documents are changed.